scispace - formally typeset
O

Olga Shamardina

Researcher at University of Cambridge

Publications -  18
Citations -  1460

Olga Shamardina is an academic researcher from University of Cambridge. The author has contributed to research in topics: BMPR2 & Gene. The author has an hindex of 10, co-authored 17 publications receiving 788 citations. Previous affiliations of Olga Shamardina include Cambridge University Hospitals NHS Foundation Trust & NHS Blood and Transplant.

Papers
More filters
Journal ArticleDOI

Whole-genome sequencing of patients with rare diseases in a national health system.

Ernest Turro, +72 more
- 02 Jul 2020 - 
TL;DR: This study used whole-genome sequencing in a national health system to streamline diagnosis and to discover unknown aetiological variants in the coding and non-coding regions of the genome, finding that rare alleles can explain the presence of some individuals in the tails of a quantitative trait for red blood cells.
Journal ArticleDOI

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Stefan Gräf, +68 more
TL;DR: In this paper, the authors performed whole-genome sequencing in 1038 pulmonary arterial hypertension (PAH) index cases and 6385 PAH-negative control subjects to identify the missing heritability.
Journal ArticleDOI

Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children

TL;DR: A gene agnostic approach was effective in identifying an underlying genetic condition, with phenotypes and symptomatology being primarily used for data interpretation rather than gene selection, and WGS analysis has the potential to be a first-line diagnostic tool for a subset of intensively ill children.
Journal ArticleDOI

Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

Paul Tuijnenburg, +157 more
TL;DR: It is shown that heterozygous loss‐of‐function variants in NFKB1 are the most common known monogenic cause of CVID, which results in a temporally progressive defect in the formation of immunoglobulin‐producing B cells.